These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 8394783)

  • 1. Cyclosporine therapy after cardiac transplantation causes hypertension and renal vasoconstriction without sympathetic activation.
    Kaye D; Thompson J; Jennings G; Esler M
    Circulation; 1993 Sep; 88(3):1101-9. PubMed ID: 8394783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclosporine-induced sympathetic activation and hypertension after heart transplantation.
    Scherrer U; Vissing SF; Morgan BJ; Rollins JA; Tindall RS; Ring S; Hanson P; Mohanty PK; Victor RG
    N Engl J Med; 1990 Sep; 323(11):693-9. PubMed ID: 2388667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Forearm vasorelaxation in hypertensive renal transplant patients: the impact of withdrawal of cyclosporine.
    van den Dorpel MA; van den Meiracker AH; Lameris TW; Weimar W; Man in't Veld AJ
    J Hypertens; 1998 Mar; 16(3):331-7. PubMed ID: 9557926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sympathetic nerve activity in renal transplant patients before and after withdrawal of cyclosporine.
    Hausberg M; Lang D; Levers A; Suwelack B; Kisters K; Tokmak F; Barenbrock M; Kosch M
    J Hypertens; 2006 May; 24(5):957-64. PubMed ID: 16612259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Normalization of total body and regional sympathetic hyperactivity in heart failure after heart transplantation.
    Rundqvist B; Elam M; Eisenhofer G; Friberg P
    J Heart Lung Transplant; 1996 May; 15(5):516-26. PubMed ID: 8771507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistence of sympathetic-mediated forearm vasoconstriction after alpha-blockade in hypertensive patients.
    Taddei S; Salvetti A; Pedrinelli R
    Circulation; 1989 Sep; 80(3):485-90. PubMed ID: 2569947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arterial hypertension in heart transplant recipients treated with triple-drug immunosuppressive therapy.
    Olivari MT; Antolick A; Ring WS
    J Heart Transplant; 1989; 8(1):34-9. PubMed ID: 2647929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fenoldopam reverses cyclosporine-induced renal vasoconstriction in kidney transplant recipients.
    Jorkasky DK; Audet P; Shusterman N; Ilson B; Dafoe D; Hedrich D; Stote RM
    Am J Kidney Dis; 1992 Jun; 19(6):567-72. PubMed ID: 1350709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin increases sympathetic activity but not blood pressure in borderline hypertensive humans.
    Anderson EA; Balon TW; Hoffman RP; Sinkey CA; Mark AL
    Hypertension; 1992 Jun; 19(6 Pt 2):621-7. PubMed ID: 1592458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased arterial stiffness in cyclosporine-treated lung transplant recipients early after transplantation.
    Silverborn M; Ambring A; Nilsson F; Friberg P; Jeppsson A
    Clin Transplant; 2004 Aug; 18(4):473-9. PubMed ID: 15233828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impairment of neurally-mediated vasoconstriction in DOCA-salt hypertensive dogs.
    Hamed AT; Lokhandwala MF
    Clin Exp Hypertens A; 1982; 4(6):867-81. PubMed ID: 6284412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of dietary potassium on blood pressure, renal function, muscle sympathetic nerve activity, and forearm vascular resistance and flow in normotensive and borderline hypertensive humans.
    Lawton WJ; Fitz AE; Anderson EA; Sinkey CA; Coleman RA
    Circulation; 1990 Jan; 81(1):173-84. PubMed ID: 2297825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclosporine causes sympathetically mediated elevations in arterial pressure in rats.
    Morgan BJ; Lyson T; Scherrer U; Victor RG
    Hypertension; 1991 Oct; 18(4):458-66. PubMed ID: 1916991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct neurohumoral evidence for isolated sympathetic nervous system activation to skeletal muscle in response to cardiopulmonary baroreceptor unloading.
    Baily RG; Prophet SA; Shenberger JS; Zelis R; Sinoway LI
    Circ Res; 1990 Jun; 66(6):1720-8. PubMed ID: 2344670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclosporine-induced hypertension: evidence for maintained baroreflex circulatory control.
    Lucini D; Milani RV; Ventura HO; Mehra MR; Messerli FH; Murgo JP; Regenstein F; Copley B; Malliani A; Pagani M
    J Heart Lung Transplant; 1997 Jun; 16(6):615-20. PubMed ID: 9229291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heart rate spectral analysis, cardiac norepinephrine spillover, and muscle sympathetic nerve activity during human sympathetic nervous activation and failure.
    Kingwell BA; Thompson JM; Kaye DM; McPherson GA; Jennings GL; Esler MD
    Circulation; 1994 Jul; 90(1):234-40. PubMed ID: 8026003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sustained vasoconstriction associated with daily cyclosporine dose in heart and lung transplant recipients: potential pathophysiologic role of endothelin.
    Pei Y; Chan C; Cattran D; Cardella C; Zaltzman J; Lopez M; Tong J; Schachter R; Maurer J
    J Lab Clin Med; 1995 Jan; 125(1):113-9. PubMed ID: 7822939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blunted vascular response to endothelin-a receptor blockade in cyclosporine-treated lung transplant recipients.
    Silverborn M; Ambring A; Nilsson F; Friberg P; Jeppsson A
    J Heart Lung Transplant; 2005 Jun; 24(6):665-70. PubMed ID: 15949725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of acute mental stress on sympathetic nerve activity and regional blood flow in advanced heart failure: implications for 'triggering' adverse cardiac events.
    Middlekauff HR; Nguyen AH; Negrao CE; Nitzsche EU; Hoh CK; Natterson BA; Hamilton MA; Fonarow GC; Hage A; Moriguchi JD
    Circulation; 1997 Sep; 96(6):1835-42. PubMed ID: 9323069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic and renal effects of nifedipine in cyclosporine-associated hypertension.
    Textor SC; Schwartz L; Wilson DJ; Wiesner R; Romero JC; Augustine J; Kos P; Hay E; Gores G; Dickson ER
    Hypertension; 1994 Jan; 23(1 Suppl):I220-4. PubMed ID: 8282363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.